Psilocybin combined with psychotherapy increased cocaine abstinent days, rates of complete abstinence, and time to relapse compared with active placebo plus psychotherapy in a randomized clinical trial of adults with cocaine use disorder. Over 180 days, psilocybin recipients were more likely to achieve sustained abstinence with no serious adverse events, supporting its potential as a novel treatment option.

Source: JAMA Network Open